Cardiovascular Systems
Cardiovascular Systems, Inc., established in 1989, specializes in developing and marketing innovative medical technologies for treating peripheral and coronary artery diseases. The company's primary product line is its orbital atherectomy systems, which employ a diamond-coated crown to remove plaque from arteries above and below the knee. These catheter-based platforms are designed to tackle challenging disease states, including calcium buildup, which is particularly prevalent in peripheral artery disease (PAD) and coronary artery disease (CAD). Cardiovascular Systems generates most of its revenue through sales of these peripheral orbital atherectomy systems in the United States.
Top Stages
3 past transactions
CarePICS
Corporate Round in 2021
CarePICS is a software development company specializing in healthcare services. It offers an online platform for remote patient monitoring and consultation, focusing on improving outcomes for patients with peripheral artery disease.
Leviticus Cardio
Venture Round in 2015
Founded in 2008 and based in Petach Tikva, Israel, Leviticus Cardio develops wireless power transfer systems for ventricular assist devices (VADs), aiming to improve the lives of heart failure patients. Its flagship product is a fully implanted ventricular assist device (FIVAD) system that eliminates the need for external power packs and drive lines, reducing infection risks.
Replidyne
Acquisition in 2008
Replidyne is a specialty pharmaceutical company dedicated to developing and commercializing innovative anti-infective products. The company focuses on addressing complex issues in skin care treatment through its bio-pharmaceutical offerings, which include oral community antibiotics and interventional treatment systems. Replidyne leverages its proprietary DNA replication technology and pursues in-licensing opportunities to enhance its development pipeline. This approach enables the company to provide a diverse range of products aimed at effectively treating skin wounds and related conditions, ultimately benefiting patients and medical providers alike.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.